Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: J Affect Disord. 2018 Jul 24;240:146–154. doi: 10.1016/j.jad.2018.07.075

Table 2:

Use of miRNA as potential molecular marker in major depressive disorder (MDD) and suicidal patients

Study # Source Participating miRNAs Clinical Diagnosis References
1 Peripheral blood
mononucleocyte
miR-107, miR-133a, miR-148a, miR-200c, miR-381, miR-
425-3p, miR-494, miR-517b, miR-579, miR-589, miR-
636, miR-652, miR-941, miR-1243
MDD Belzeaux et al., 2012
2 Blood serum miR-132 and miR-182 MDD Li et al., 2013
3 Peripheral blood
mononucleocyte
miRNA-26b, miRNA-1972, miRNA-4485, miRNA-4498,
and miRNA-4743
MDD Fan et al., 2014
4 Cerebrospinal fluid miR-221-3p, miR-34a-5p, let-7d-3p, miR-451a MDD Wan et al., 2015
5 Blood serum miR-124-3p MDD Roy et al., 2017b
6 Peripheral blood
mononucleocyte
miR-124-3p MDD He et al., 2016
7 Whole blood miR-146a-5p, miR-146b-5p, miR-425-3p, miR-24-3p MDD Lopez et al., 2017
8 Peripheral blood
mononucleocyte
miR-19a-3p MDD-Suicide Wang et al., 2018